Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
22.03. | Ex-Prometheus Executives Launch Mirador Therapeutics | ||
22.03. | Italfarmaco S.p.A.'s Duvyzat Approved by FDA | ||
21.03. | Qosina Names David Oh to Represent Korean Market | ||
21.03. | Idorsia's TRYVIO Approved by FDA for the Treatment of Hypertension | ||
21.03. | Batavia and Candel Partner to Accelerate Development of CAN-3110 | ||
21.03. | Charles River Extends Gene Therapy Alliance with NUS Medicine | ||
20.03. | BioNTech 4Q Earnings Hit by Drop in Covid Vax Sales | ||
20.03. | BioNTech Appoints Annemarie Hanekamp Chief Commercial Officer | ||
20.03. | Tonix Pharmaceuticals Selects 2 CMOs to Support Tonmya in the U.S. | ||
20.03. | Novo Nordisk to Invest $566M in Tianjin, China Facility | ||
20.03. | Bayer, Thermo Fisher Partner to Advance Access to Precision Cancer Medicines | ||
20.03. | Ampersand Capital Partners Acquires Full-Service Manufacturer Biologos | ||
20.03. | Lonza Acquires Biologics Manufacturing Site from Roche for $1.2B | ||
20.03. | Celanese & Secarna Partner for the Development of Implants that Deliver ASOs | ||
20.03. | Intra-Cellular Therapies Promotes Dr. Michael Halstead to President | ||
20.03. | Conduit Pharmaceuticals Names Dr. Joanne Holland as Chief Scientific Officer | ||
19.03. | Morphic Therapeutic Taps Simon Cooper as Chief Medical Officer | ||
19.03. | Nascent Biotech & HypoSpray Pharma Collaborate on Proprietary Transdermal Delivery System | ||
19.03. | White Raven Selects Cytiva for Aseptic Filling Needs | ||
19.03. | Forge's AAV Gene Therapy Granted Innovation Passport Designation in Krabbe Disease | ||
19.03. | Kindeva Names Jennifer Riter VP of Analytical Services | ||
19.03. | AstraZeneca to Acquire Fusion Pharmaceuticals in Potential $2.4B Deal | ||
19.03. | AGC Biologics to Manufacture Orchard Therapeutics' Lenmeldy | ||
19.03. | Hovione, GEA Advance Continuous Tableting Technology Partnership | ||
18.03. | Parexel Announces CEO Transition |